1

Mini-antibodies Restore tumor suppressor p53: The New Pathway for Malignant Management

News Discuss 
A significant discovery in cancer study is occurring with the use of VHH fragments to reactivate damaged p53. This essential malignant suppressor protein is frequently disabled in several types of tumors, leading https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research

Comments

    No HTML

    HTML is disabled


Who Upvoted this Story